Axon Enterprise, Inc.

(NASDAQ Global Select)
Slightly Bullish +25

Axon Enterprise (NASDAQ:AXON) Shares Down 5.8% - Should You Sell? - MarketBeat

πŸ“‰ Axon shares fell 5.8% to $565.83 amid a high 234.02x P/E ratio and trading volume 67% below the session average.

πŸ’° Revenue surged 35.3% year-over-year to $904.39 million, significantly topping analyst expectations of $876.42 million.

πŸ“ˆ EPS beat estimates at $1.88 versus the consensus of $1.84, with a net margin of 6.19% and ROE of 2.84%.

πŸ‘ Analyst consensus remains 'Moderate Buy' with an average price target of $730.92, implying potential upside from current levels.

πŸ“‰ Insiders sold 75,401 shares worth approximately $40.7 million over the last 90 days under Rule 10b5-1 trading plans.

🏦 Institutional ownership stands at 79.08%, with hedge funds holding significant stakes in the company's stock.

Bullish Signals
  • Axon reported quarterly revenue of $904.39 million, a robust 35.3% year-over-year increase that significantly exceeded analyst forecasts.
  • The company beat earnings per share estimates with actual results of $1.88 compared to the consensus expectation of $1.84.
  • Wall Street maintains a 'Moderate Buy' consensus rating with 13 buy ratings and an average price target of $730.92, suggesting upside potential.
  • Axon's hardware portfolio includes conducted energy weapons and body-worn cameras paired with a subscription-based software platform for digital evidence management.
Risk Factors
  • Shares declined 5.8% to $565.83, trading at a very high price-to-earnings ratio of 234.02 which may limit near-term upside.
  • Insiders sold a total of 75,401 shares worth approximately $40.7 million over the past 90 days, signaling potential profit-taking or lack of confidence at current levels.
Full Analysis
Axon Enterprise (NASDAQ:AXON) shares declined 5.8% to approximately $565.83 in mid-day trading, driven by a high valuation multiple of 234.02 times earnings and lower-than-average trading volume. Despite the price drop, the company recently reported strong quarterly financial results, with revenue reaching $904.39 million, a 35.3% year-over-year increase that significantly exceeded analyst forecasts of $876.42 million. The company also beat earnings per share estimates, reporting $1.88 versus the expected $1.84, while maintaining a net margin of 6.19%. Wall Street sentiment remains largely positive, with a consensus 'Moderate Buy' rating from 13 analysts and an average price target of $730.92, suggesting potential upside despite recent volatility. However, insider activity presents a contrasting signal, as executives sold approximately 75,401 shares worth roughly $40.7 million over the past 90 days under pre-arranged trading plans. While hedge fund ownership remains high at 79.08%, some analysts have recently downgraded their ratings or adjusted price targets, indicating mixed perspectives on the stock's current trajectory.